Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Update on clinical progression of Amylin's diabetes drug

June 25, 1997

DuPont Merck seeks to license cholesterol-lowering agent

June 25, 1997

Hypocholesterolemic compounds reported by Schering-Plough

June 23, 1997

Promising results reported for Senetek's INVICORP for male erectile dysfunction

June 19, 1997

Novartis and Osiris Therapeutics to codevelop bone and cartilage disease therapies

June 18, 1997

First clinical trials results reported for leptin

June 18, 1997

Zonagen reports results of second phase III trial of Vasomax

June 17, 1997

New vial size of generic leucovorin approved by FDA

June 17, 1997

Vitamin E for maternal diabetes-associated malformations in offspring

June 16, 1997

Neurogen reports promising phase I results with antiobesity drug

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...